New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2013
11:31 EDTCVLT, AET, IRM, MW, RADHigh option volume stocks: MW RAD CVLT AET IRM
News For MW;RAD;CVLT;AET;IRM From The Last 14 Days
Check below for free stories on MW;RAD;CVLT;AET;IRM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 29, 2014
06:13 EDTAETAetna expects to achieve targeted high single-digit pretax operating margin 2014
06:03 EDTAETAetna reports Q2 operating EPS $1.69, consensus $1.60
Subscribe for More Information
July 28, 2014
15:47 EDTAETNotable companies reporting before tomorrow's open
Subscribe for More Information
14:58 EDTAETEarnings Preview: Aetna shares up 16% since last earnings report
Subscribe for More Information
11:00 EDTCVLTHigh option volume stocks:
Subscribe for More Information
10:36 EDTAETAetna and Geisinger Health System reach five-year agreement
Subscribe for More Information
07:30 EDTMWMen's Wearhouse to host analyst day
Subscribe for More Information
July 25, 2014
13:13 EDTRADEinhorn bought Lam Research shares, sold Rite Aid last quarter
Subscribe for More Information
12:11 EDTAETWellCare profit warning sinks managed care names
A number of managed care names are falling after one of the companies in the sector, WellCare (WCG), preannounced significantly weaker than expected results. UBS, however, recommends using the weakness in the sector as a buying opportunity. WHAT'S NEW: WellCare, which specializes in managing Medicaid and Medicare plans, preannounced a second quarter per share loss of 7c, excluding certain items. Analysts on average expected the company to report a per share profit of 90c. The company's revenue came in slightly above expectations. WellCare cut its full-year earnings per share guidance to $2.20-$2.50 from $4.40-$4.75. The company said recipients of a new Medicaid program in Florida utilized more medical services than expected since the company began administering the program in May. Additionally, the company took an impairment charge related to an acquisition and it had an unfavorable reserve development. ANALYST REACTION: The factors cited by WellCare for the cut in its guidance appear to be specific to that company, UBS analyst A.J. Rice wrote. Meanwhile, data from other companies that administer Medicaid plans indicate that the increased utilization costs in that state are also specific to WellCare, Rice contended. For example, Centene (CNC) reported Q2 results earlier this week and indicated that utilization trends for newly covered beneficiaries in Florida was largely in line with expectations, while UnitedHealth (UNH) said its Medicaid business had performed well last quarter, the analyst stated. Additionally, WellCare said that its higher than expected medical utilization costs had been caused primarily by drug costs that exceeded its forecast, Rice stated. Since drug costs tend to be known relatively quickly, United Health and Centene would have divulged any issues with drug costs in conjunction with their Q2 results, Rice said. The analyst recommended that investors buy Aetna (AET), Cigna (CI), United Health and WellPoint (WLP) on any weakness today. PRICE ACTION: In late morning trading, Aetna fell 1.5% to $83, Cigna lost 1% to $95.50, UnitedHealth lost 1% to $84.50, WellPoint slid 1.5% to $113.50 and Centene tumbled 7% to $74 while WellCare plunged 19% to $62.
10:52 EDTAETWellCare issues largely company-specific, says UBS
UBS notes that aside from WellCare (WCG), which attributed its lowered guidance to the start-up of its Florida MMA program and other issues, that Centene (CNC), WellPoint (WLP), UnitedHealth (UNH) and Humana (HUM) are the leaders in Medicaid in the state. However, the firm believes a majority of WellCare's issues appear company specific and UBS views any weakness in UnitedHealth, WellPoint, Aetna (AET), or Cigna (CI) as opportunity to buy those four stocks, on all of which it has Buy ratings.
July 24, 2014
16:09 EDTRADRite Aid names Darren Karst as executive VP, CFO
Subscribe for More Information
16:05 EDTRADRoundy's CFO Karst leaves for Rite-Aid, names Michael Turzenski as CFO
Roundy’s (RNDY) announced that Darren Karst, Roundy’s executive VP and CFO will be leaving the company to join Rite Aid (RAD) as its executive VP and CFO. Karst will remain with Roundy’s through August 9. Michael Turzenski, currently Roundy’s group VP and Chief Accounting Officer, has been appointed group VP, CFO by Roundy’s board. Turzenski has served as group VP, Chief Accounting Officer since February 2012. Turzenski joined Roundy’s in 2007 as VP, controller.
06:50 EDTAETConsumers received $9B in refunds from health insurers, The Hill says
Subscribe for More Information
July 23, 2014
10:02 EDTMWOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:53 EDTMWMen's Wearhouse reinstated with a Buy at Goldman
Target $72.
July 22, 2014
13:46 EDTAETCourt upholds Obamacare subsidies, NY Times says
Subscribe for More Information
10:43 EDTAETAppeals court bars subsidies in health care law
A three-judge panel of the D.C. Circuit Court of Appeals struck down part of President Obama's healthcare law by siding today with plaintiffs who argued that the law barred the government from giving subsidies to people in states that chose not to set up their own insurance marketplaces. The appeals court stated, "Because we conclude that the ACA unambiguously restricts the section 36B subsidy to insurance purchased on Exchanges 'established by the State,' we reverse the district court and vacate the IRS’s regulation." Twenty-seven states decided against setting up marketplaces, and another nine states partially opted out, according to the Washington Post.
July 18, 2014
10:03 EDTIRMOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:42 EDTIRMIron Mountain downgraded at RW Baird
As previously reported, Baird downgraded Iron Mountain to Neutral from Outperform. The firm expects the REIT conversion will require significant capital commitments due to the high dividend, which will leave little capital for larger growth investments. Additionally, the analyst believe equity dilution risk is not fully appreciated. Price target lowered to $39 from $40.
06:11 EDTIRMIron Mountain downgraded to Neutral from Outperform at RW Baird
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use